abstract
- Activist groups have been successful in promoting research and better treatment for people with HIV infection, but they can also stop trials if their views are not considered
Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- December 10, 2005
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Clinical Trials as Topic (MeSH)
- General & Internal Medicine (Science Metrix)
- HIV Infections (MeSH)
- Humans (MeSH)
- Patient Satisfaction (MeSH)
- Research Design (MeSH)
- Self-Help Groups (MeSH)
- Vulnerable Populations (MeSH)
published in
- The BMJ Journal